Predictors of Poor Outcome of Anti‐MDA5‐Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis

Abstract

Anti-MDA5-associated RP-ILD is significantly associated with poor survival rates in DM/CADM patients. More effective intervention should be administered to anti-MDA5-associated RP-ILD patients, especially to senior patients and those without periungual erythema.